Searchable abstracts of presentations at key conferences in endocrinology

ea0028s6.2 | Inhibiting steroid enzymes to treat common diseases | SFEBES2012

Old drugs for new targets - CYP11B2 inhibitors for hypertension

Bernhardt Rita

The aldosterone synthase (CYP11B2), being 93 % identical in its primary structure to CYP11B1, catalyses the 11beta-hydroxylation, 18-hydroxylation and 18-oxidation of deoxycorticosterone to form aldosterone. CYP11B2 is an important target for the development of drugs, since overproduction of aldosterone may lead to hypertension as well as heart failure. Thus, besides the mineralocorticoid receptor, CYP11B2 seems to be a potent target for drug development. To find specific inhi...

ea0031p326 | Steroids | SFEBES2013

Identification of a novel CYP11B1 isoform in human adrenocortical cells

Alvarez-Madrazo Samantha , MacKenzie Scott , Brinth Alette , Fraser Niall , Bernhardt Rita , Connell John , Davies Eleanor

The final reaction for cortisol production in the adrenal gland is catalysed by the 11β-hydroxylase enzyme, encoded by the CYP11B1 gene. Variants in this gene have been associated with alterations in cortisol levels, which increase blood pressure. This gene is traditionally thought to consist of 9 exons. However, recent evidence has predicted the existence of at least one alternatively spliced form.The presence of novel CYP11B1 mRN...